A recent report published by Infinium Global Research on
therapeutic vaccines market provides in-depth analysis of segments and
sub-segments in global as well as regional therapeutic vaccines market. The
study also highlights the impact of drivers, restraints and macro indicators on
the global and regional therapeutic vaccines market over the short term as well
as long term. The report is a comprehensive presentation of trends, forecast
and dollar values of global therapeutic vaccines market. According to the report, the global therapeutic vaccines market is projected to grow at a CAGR of 7.3%
over the forecast period of 2018-2024.
Therapeutic vaccines aren't used
for prevention. Instead, they're used as a method of treatment. Therapeutic
vaccines are used to stimulate the immune system to target infection or a
type of diseased cells-such as a cancer cell. complications of chronic diseases
such as pneumococcal disease, DTP, influenza, human papillomavirus,
meningococcal disease, polio, hepatitis, and varicella dengue. It is
accomplished by controlling the presence of viruses in the blood and reducing
the viral set-point in infected people. According to the U.S. food and drug
administration, promising results from clinical trials recently led to the
approval of the first therapeutic cancer vaccine. According to the world health
organization "allergen immunotherapy therapeutic vaccines for allergic
diseases." the historical term allergen extract was changed to allergen
vaccine to reflect the fact that allergen vaccines are used in medicine as
immune modifiers.
The major driving factor such as the increasing occurrence
of cancer, cardiovascular diseases, HIV infection, and various chronic diseases
are boosting the therapeutic vaccines market. In addition, Increase in
funding’s from the government for vaccine development and growing awareness among people
for severe disease are the key factors escalating the growth of therapeutic vaccines market. However, the high cost associated with treatment is expected to
hinder the growth of therapeutic vaccines market. Moreover, various
pharmaceutical players in this market are extensively researching on the research
& Development activities to develop novel vaccines for several diseases
that may create growth opportunities for therapeutic vaccines market in the
near future.
Among the geographies, North
America is the leading contributor to the therapeutic vaccines market. The U.S
has the largest market share in the North America region. Developed medical and
healthcare infrastructure and increasing funding for research and development
activities are the few factors augmenting the growth in the North America
region. On the other hand, the Asia-Pacific region is anticipated to be the fastest
growing market in the upcoming year owing to the increasing prevalence of various
diseases, rising disposable income and rapidly growing aging population.
The report on global therapeutic vaccines market covers
segments such as vaccines type, disease indication, administration, and end
user. On the basis of vaccines type the global therapeutic vaccines market is categorized into auto immune diseases
vaccines, neurological disease vaccines, chronic disease vaccines, and
infectious diseases vaccines. On the basis of disease indication, the global therapeutic vaccines market is categorized into pneumococcal disease,
DTP, influenza, human papillomavirus, meningococcal
disease, polio, hepatitis, MMR, varicella, and dengue.
On the basis of administration, the global therapeutic vaccines market is
categorized into intramuscular and subcutaneous administration, oral
administration and other routes of administration. On the basis of end
user the global therapeutic vaccines market is categorized into pediatrics and
adults.
The countries covered in the North America region include the U.S., Canada, and Mexico; while Asia-Pacific includes China, Japan, India, South Korea, Malaysia, and among others. Moreover, Germany, U.K., France, Spain, and Rest of Europe are included in the European region.
The U.S. drives the
growth in the North America region as it is the largest market in the region.
The Asia-Pacific region offers a substantial potential for the market growth
owing to rapid growth in markets such as India and China. The APAC region is
projected to experience a growth at a CAGR of x.x% over the period of 2018-2024.
The report provides profiles of the companies in the global therapeutic vaccines market such as Pfizer, Inc., GlaxoSmithKline PLC., Merck & Co., Inc., Sanofi Pasteur SA, CSL Limited, Emergent Biosolutions, Inc., Johnson & Johnson, MedImmune, LLC (A Subsidiary of AstraZeneca), Astellas Pharma, Inc. and Serum Institute of India.
The report provides deep insights on demand forecasts, market
trends, and micro and macro indicators. In addition, this report provides
insights into the factors that are driving and restraining the global therapeutic
vaccines market. Moreover, IGR-Growth Matrix analysis given in the report brings
an insight into the investment areas that existing or new market players can
consider. The report provides insights into the market using analytical tools
such as Porter's five forces analysis and DRO analysis of therapeutic vaccines
market. Moreover, the study highlights current market trends and provides
forecast from 2018-2024. We also have highlighted future trends in the
therapeutic vaccines market that will impact the demand during the forecast
period. Moreover, the competitive analysis given in each regional market brings
an insight into the market share of the leading players. This report will help
manufacturers, suppliers, and distributors of the therapeutic vaccines market to
understand the present and future trends in this market and formulate their
strategies accordingly.
Please Choose One of them.